Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Guardant Health Inc
(NQ:
GH
)
18.10
+0.76 (+4.38%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,796,232
Open
17.72
Bid (Size)
17.82 (1)
Ask (Size)
18.28 (2)
Prev. Close
17.34
Today's Range
17.34 - 18.11
52wk Range
15.81 - 41.06
Shares Outstanding
101,298,669
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Key Takeaways From Guardant Health Analyst Ratings
Today 14:01 EDT
Via
Benzinga
Matterport, Sea Limited, Ingevity And Other Big Stocks Moving Higher On Monday
April 22, 2024
Via
Benzinga
Performance
YTD
-31.72%
-31.72%
1 Month
+5.66%
+5.66%
3 Month
-19.70%
-19.70%
6 Month
-29.43%
-29.43%
1 Year
-15.62%
-15.62%
More News
Read More
FDA Advisory Panel Review of Guardant Health’s Shield™ Blood Test to Screen for Colorectal Cancer to Be Held on May 23
April 22, 2024
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health to Report First Quarter 2024 Financial Results on May 9, 2024
April 18, 2024
From
Guardant Health, Inc.
Via
Business Wire
Analyst Expectations For Guardant Health's Future
April 05, 2024
Via
Benzinga
4 Analysts Have This To Say About Guardant Health
February 23, 2024
Via
Benzinga
Guardant Health: Q4 Earnings Insights
February 22, 2024
Via
Benzinga
Decoding 4 Analyst Evaluations For Guardant Health
January 30, 2024
Via
Benzinga
Guardant Health to Present Data Highlighting Application of Epigenomics to Advance Precision Oncology at 2024 AACR Annual Meeting
April 03, 2024
From
Guardant Health, Inc.
Via
Business Wire
Exact Sciences, A Cathie Wood Stock, Surges As Rival Colon Cancer Test Pales
April 02, 2024
Via
Investor's Business Daily
Better Than ChatGPT? New Super AI Bot Says Buy These 3 Stocks.
April 01, 2024
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
REX American Resources Reports Upbeat Earnings, Joins Avalo Therapeutics, RH And Other Big Stocks Moving Higher On Thursday
March 28, 2024
Via
Benzinga
Insiders Buying Advance Auto Parts And 2 Other Stocks
March 20, 2024
Via
Benzinga
Guardant Health ECLIPSE Study Data Demonstrating Efficacy of Shield Blood-based Test for Colorectal Cancer Screening to be Published in The New England Journal of Medicine
March 13, 2024
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 06, 2024
From
Guardant Health, Inc.
Via
Business Wire
New Survey: Patients and Physicians Overwhelmingly Agree Blood Tests Could Help Close the Colorectal Cancer Screening Gap
March 01, 2024
From
Guardant Health, Inc.
Via
Business Wire
Cancer Test Focused Guardant Health Stock Falls On FDA AdCom Update For Colorectal Test
February 23, 2024
Via
Benzinga
Exposures
Product Safety
Guardant Health Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Outlook
February 22, 2024
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health to Participate in Upcoming Investor Conferences
February 15, 2024
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health to Report Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024
February 01, 2024
From
Guardant Health, Inc.
Via
Business Wire
3 Stocks to Buy for the Age of Personalized Medicine
January 28, 2024
Via
InvestorPlace
Guardant Health to present data at ASCO GI supporting use of liquid biopsy to predict colon cancer recurrence
January 17, 2024
From
Guardant Health, Inc.
Via
Business Wire
Bull of the Day - NeoGenomics
January 12, 2024
Via
Talk Markets
Topics
Intellectual Property
Exposures
Intellectual Property
7 Small-Cap Stocks to Best Position Your Portfolio for a Strong 2024
January 08, 2024
Via
InvestorPlace
Guardant Health Announces Preliminary Fourth Quarter and Full Year 2023 Results
January 08, 2024
From
Guardant Health, Inc.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.